Key points are not available for this paper at this time.
Design
Review
No takes yet. Share an insight, caveat, or question.
miRNAs remain investigational targets in AF remodeling; leaves open the need for validation trials before any clinical consideration.
Zhang et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: